Kyverna Therapeutics Inc (KYTX)

Apr 20, 2025

JPMorgan Chase & Co. Sells 220,915 Shares of Kyverna Therapeutics, Inc. (NASDAQ:KYTX) - MarketBeat

Apr 20, 2025

Apr 20, 2025

4,126,119 Shares in Kyverna Therapeutics, Inc. (NASDAQ:KYTX) Bought by Gilead Sciences Inc. - MarketBeat

Apr 20, 2025

Apr 19, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 19, 2025

Apr 18, 2025

Kyverna Therapeutics, Inc. (NASDAQ:KYTX) Shares Sold by Franklin Resources Inc. - MarketBeat

Apr 18, 2025

Apr 17, 2025

Notice to Long-Term Shareholders of Kyverna Therapeutics, Inc. (NASDAQ: KYTX); Methode - Bluefield Daily Telegraph

Apr 17, 2025

Apr 17, 2025

Notice to Long-Term Shareholders of Kyverna Therapeutics, - GlobeNewswire

Apr 17, 2025

Apr 17, 2025

Notice to Long-Term Shareholders of Kyverna Therapeutics, Inc. (NASDAQ: KYTX); Methode Electronics, Inc. (NYSE: MEI); ModivCare, Inc. (NASDAQ: MODV); and Monolithic Power Systems, Inc. (NASDAQ: MPWR)Grabar Law Office Is Investigating Claims - TradingView

Apr 17, 2025

Apr 16, 2025

Investigation announced for Long-Term Investors in shares of Kyverna Therapeutics, Inc. (NASDAQ: KYTX) - openPR.com

Apr 16, 2025

Apr 15, 2025

Robbins LLP Reminds Kyverna Therapeutics, Inc. Investors of the Pending Securities Fraud Class Action Against KYTX - marketscreener.com

Apr 15, 2025

Apr 15, 2025

Kyverna Therapeutics Files For Offering Of Up To $50 Mln Common Stock From Time To TimeSEC Filing - marketscreener.com

Apr 15, 2025

Apr 11, 2025

HC Wainwright Has Negative Outlook for KYTX Q1 Earnings - MarketBeat

Apr 11, 2025

Apr 08, 2025

HC Wainwright Cuts Kyverna Therapeutics (NASDAQ:KYTX) Price Target to $4.00 - MarketBeat

Apr 08, 2025

Apr 07, 2025

KYTX stock plunges to 52-week low, touches $1.85 amid market rout - Investing.com Australia

Apr 07, 2025

Apr 07, 2025

KYTX stock plunges to 52-week low, touches $1.85 amid market rout By Investing.com - Investing.com South Africa

Apr 07, 2025

Apr 05, 2025

Kyverna Therapeutics, Inc. (NASDAQ:KYTX) Given Average Recommendation of "Buy" by Analysts - MarketBeat

Apr 05, 2025

Apr 05, 2025

Morgan Stanley Has Lowered Expectations for Kyverna Therapeutics (NASDAQ:KYTX) Stock Price - MarketBeat

Apr 05, 2025

Apr 03, 2025

Levi & Korsinsky Reminds Kyverna Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 7, 2025KYTX - ACCESS Newswire

Apr 03, 2025

Apr 03, 2025

H.C. Wainwright cuts Kyverna Therapeutics price target to $4 - Investing.com Australia

Apr 03, 2025

Apr 03, 2025

KYTX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Kyverna Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Apr 03, 2025

Apr 03, 2025

KYTX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Kyverna Therapeutics, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Apr 03, 2025

Apr 03, 2025

H.C. Wainwright cuts Kyverna Therapeutics price target to $4 By Investing.com - Investing.com Canada

Apr 03, 2025

Apr 01, 2025

Kyverna Therapeutics price target lowered to $20 from $40 at Morgan Stanley - TipRanks

Apr 01, 2025

Mar 31, 2025

ALERT: Grabar Law Office Investigates Claims for Long-Term Shareholders of Holley Inc. (NYSE: HLLY); Integra Lifesciences Holdings Corporation (NASDAQ: IART); Kyverna Therapeutics, Inc. (NASDAQ: KYTX); and Virtu Financial, Inc. (NASDAQ: VIRT) - GlobeNewswire

Mar 31, 2025

Mar 31, 2025

Kyverna Therapeutics Advances CAR T-Cell Therapy Trials - MSN

Mar 31, 2025

Mar 31, 2025

Kyverna Therapeutics price target lowered to $12 from $13 at UBS - MSN

Mar 31, 2025

Mar 31, 2025

Kyverna Therapeutics (NASDAQ:KYTX) Announces Quarterly Earnings Results - MarketBeat

Mar 31, 2025

Mar 30, 2025

KYVERNA THERAPEUTICS Earnings Preview: Recent $KYTX Insider Trading, Hedge Fund Activity, and More - Nasdaq

Mar 30, 2025

Mar 28, 2025

KYTX stock touches 52-week low at $2.2 amid sharp annual decline - Investing.com

Mar 28, 2025

Mar 28, 2025

Kyverna Therapeutics inks sales agreement with Jefferies By Investing.com - Investing.com Canada

Mar 28, 2025

Mar 27, 2025

Kyverna Therapeutics Inc. (KYTX) reports earnings - Quartz

Mar 27, 2025

Mar 27, 2025

Kyverna Therapeutics inks sales agreement with Jefferies - Investing.com India

Mar 27, 2025

Mar 27, 2025

Kyverna Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results - GuruFocus

Mar 27, 2025

Mar 27, 2025

Kyverna Therapeutics Inc Strong Balance Sheet Extends Cash Runway Into 2027 Through Key Clinical And Regulatory Catalysts - MarketScreener

Mar 27, 2025

Mar 27, 2025

Kyverna Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 27, 2025